세계의 윌슨병 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Wilson's Disease was estimated to be worth US$ 221 million in 2024 and is forecast to a readjusted size of US$ 294 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.

Wilson's disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson's disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson's disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson's disease occurs worldwide with prevalence of approximately 30 individuals affected per million.

The Wilson's Disease market is primarily driven by increasing awareness and improved diagnostic capabilities that enable earlier detection of this rare genetic disorder. Advances in genetic testing and biochemical assays have facilitated timely diagnosis, allowing for earlier intervention and better management of the disease. Additionally, growing investment in research and development of novel therapies, including gene therapy and RNA interference (RNAi), is fueling market growth by offering the potential for more effective and less toxic treatment options. Rising healthcare expenditure and expanding patient support programs also contribute to the increasing accessibility of treatment.

Despite advancements, the Wilson's Disease market faces significant challenges, including the rarity of the condition, which limits patient populations and reduces incentives for extensive drug development. Existing treatments, such as chelating agents and zinc therapies, often have side effects and require lifelong adherence, leading to compliance issues. High costs associated with emerging therapies, regulatory hurdles, and the need for more comprehensive clinical trials also pose barriers to market growth. Moreover, limited awareness among healthcare providers and patients in certain regions can delay diagnosis and treatment initiation, further complicating disease management.

This report aims to provide a comprehensive presentation of the global market for Wilson's Disease, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Wilson's Disease by region & country, by Type, and by Application.

The Wilson's Disease market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wilson's Disease.

Market Segmentation

By Company

• Bausch Health
• Teva
• ANI Pharmaceuticals
• Tsumura
• MSN Laboratories
• Kadmon Holdings
• Orphalan
• Endo International
• Univar Solutions
• APOTEX
• Sinepharm
• Taj Pharmaceutical

Segment by Type

• Trientine
• Penicillamine
• Others

Segment by Application

• Hospital
• Drugs Stores
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Wilson's Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Wilson's Disease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Wilson's Disease in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Wilson's Disease Product Introduction
• 1.2 Global Wilson's Disease Market Size Forecast (2020-2031)
• 1.3 Wilson's Disease Market Trends & Drivers
  • 1.3.1 Wilson's Disease Industry Trends
  • 1.3.2 Wilson's Disease Market Drivers & Opportunity
  • 1.3.3 Wilson's Disease Market Challenges
  • 1.3.4 Wilson's Disease Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Wilson's Disease Players Revenue Ranking (2024)
• 2.2 Global Wilson's Disease Revenue by Company (2020-2025)
• 2.3 Key Companies Wilson's Disease Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Wilson's Disease Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Wilson's Disease
• 2.6 Wilson's Disease Market Competitive Analysis
  • 2.6.1 Wilson's Disease Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Wilson's Disease Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wilson's Disease as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Trientine
  • 3.1.2 Penicillamine
  • 3.1.3 Others
• 3.2 Global Wilson's Disease Sales Value by Type
  • 3.2.1 Global Wilson's Disease Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Wilson's Disease Sales Value, by Type (2020-2031)
  • 3.2.3 Global Wilson's Disease Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Drugs Stores
  • 4.1.3 Others
• 4.2 Global Wilson's Disease Sales Value by Application
  • 4.2.1 Global Wilson's Disease Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Wilson's Disease Sales Value, by Application (2020-2031)
  • 4.2.3 Global Wilson's Disease Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Wilson's Disease Sales Value by Region
  • 5.1.1 Global Wilson's Disease Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Wilson's Disease Sales Value by Region (2020-2025)
  • 5.1.3 Global Wilson's Disease Sales Value by Region (2026-2031)
  • 5.1.4 Global Wilson's Disease Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Wilson's Disease Sales Value, 2020-2031
  • 5.2.2 North America Wilson's Disease Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Wilson's Disease Sales Value, 2020-2031
  • 5.3.2 Europe Wilson's Disease Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Wilson's Disease Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Wilson's Disease Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Wilson's Disease Sales Value, 2020-2031
  • 5.5.2 South America Wilson's Disease Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Wilson's Disease Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Wilson's Disease Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Wilson's Disease Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Wilson's Disease Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Wilson's Disease Sales Value, 2020-2031
  • 6.3.2 United States Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Wilson's Disease Sales Value, 2020-2031
  • 6.4.2 Europe Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Wilson's Disease Sales Value, 2020-2031
  • 6.5.2 China Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Wilson's Disease Sales Value, 2020-2031
  • 6.6.2 Japan Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Wilson's Disease Sales Value, 2020-2031
  • 6.7.2 South Korea Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Wilson's Disease Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Wilson's Disease Sales Value, 2020-2031
  • 6.9.2 India Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Wilson's Disease Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Bausch Health
  • 7.1.1 Bausch Health Profile
  • 7.1.2 Bausch Health Main Business
  • 7.1.3 Bausch Health Wilson's Disease Products, Services and Solutions
  • 7.1.4 Bausch Health Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Bausch Health Recent Developments
• 7.2 Teva
  • 7.2.1 Teva Profile
  • 7.2.2 Teva Main Business
  • 7.2.3 Teva Wilson's Disease Products, Services and Solutions
  • 7.2.4 Teva Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Teva Recent Developments
• 7.3 ANI Pharmaceuticals
  • 7.3.1 ANI Pharmaceuticals Profile
  • 7.3.2 ANI Pharmaceuticals Main Business
  • 7.3.3 ANI Pharmaceuticals Wilson's Disease Products, Services and Solutions
  • 7.3.4 ANI Pharmaceuticals Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.3.5 ANI Pharmaceuticals Recent Developments
• 7.4 Tsumura
  • 7.4.1 Tsumura Profile
  • 7.4.2 Tsumura Main Business
  • 7.4.3 Tsumura Wilson's Disease Products, Services and Solutions
  • 7.4.4 Tsumura Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Tsumura Recent Developments
• 7.5 MSN Laboratories
  • 7.5.1 MSN Laboratories Profile
  • 7.5.2 MSN Laboratories Main Business
  • 7.5.3 MSN Laboratories Wilson's Disease Products, Services and Solutions
  • 7.5.4 MSN Laboratories Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.5.5 MSN Laboratories Recent Developments
• 7.6 Kadmon Holdings
  • 7.6.1 Kadmon Holdings Profile
  • 7.6.2 Kadmon Holdings Main Business
  • 7.6.3 Kadmon Holdings Wilson's Disease Products, Services and Solutions
  • 7.6.4 Kadmon Holdings Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Kadmon Holdings Recent Developments
• 7.7 Orphalan
  • 7.7.1 Orphalan Profile
  • 7.7.2 Orphalan Main Business
  • 7.7.3 Orphalan Wilson's Disease Products, Services and Solutions
  • 7.7.4 Orphalan Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Orphalan Recent Developments
• 7.8 Endo International
  • 7.8.1 Endo International Profile
  • 7.8.2 Endo International Main Business
  • 7.8.3 Endo International Wilson's Disease Products, Services and Solutions
  • 7.8.4 Endo International Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Endo International Recent Developments
• 7.9 Univar Solutions
  • 7.9.1 Univar Solutions Profile
  • 7.9.2 Univar Solutions Main Business
  • 7.9.3 Univar Solutions Wilson's Disease Products, Services and Solutions
  • 7.9.4 Univar Solutions Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.9.5 Univar Solutions Recent Developments
• 7.10 APOTEX
  • 7.10.1 APOTEX Profile
  • 7.10.2 APOTEX Main Business
  • 7.10.3 APOTEX Wilson's Disease Products, Services and Solutions
  • 7.10.4 APOTEX Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.10.5 APOTEX Recent Developments
• 7.11 Sinepharm
  • 7.11.1 Sinepharm Profile
  • 7.11.2 Sinepharm Main Business
  • 7.11.3 Sinepharm Wilson's Disease Products, Services and Solutions
  • 7.11.4 Sinepharm Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.11.5 Sinepharm Recent Developments
• 7.12 Taj Pharmaceutical
  • 7.12.1 Taj Pharmaceutical Profile
  • 7.12.2 Taj Pharmaceutical Main Business
  • 7.12.3 Taj Pharmaceutical Wilson's Disease Products, Services and Solutions
  • 7.12.4 Taj Pharmaceutical Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.12.5 Taj Pharmaceutical Recent Developments

8 Industry Chain Analysis

• 8.1 Wilson's Disease Industrial Chain
• 8.2 Wilson's Disease Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Wilson's Disease Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Wilson's Disease Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer